publication venue for
- Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells. 41:64-72. 2018
- Identification of Synthetic Peptides that Inhibit Lipopolysaccharide (LPS) Binding to Myeloid Differentiation Protein-2 (MD-2). 36:197-207. 2013
- In Vivo Antitumor Efficacy of Tumor-Draining Lymph Node Cells Activated with Nonspecific T-Cell Reagents. 14:279-285. 1993
- Dual-specific T Cells: Combining Car-engineered T Cells With Oncolytic Virotherapy 2012
- Rapamycin Treatment Endows Car-engineered CD8+Effector T Cells With Memory-like Properties Resulting in Enhanced in vivo Engraftment 2012
- Development of a Novel Chimeric Antigen Receptor Targeting the Melanoma Antigen GP75 2010
- Investigating the Impact of Autophagy Modulation on Dendritic Cell Cancer Vaccines 2010
- Cytotoxic therapies can enhance the efficacy of therapeutic cancer Vaccines but the outcome remains limited by antigen selection and the development of antigen-loss variants 2007
- Discovery and characterization of new antigens for therapeutic vaccination against breast cancer 2003